NONMEM Users Network Archive

Hosted by Cognigen

Re: Pharmacoeconomic simulations

From: jeffrey.a.wald
Date: Thu, 23 Apr 2009 16:38:43 -0400

A clinical utility index (CUI), as described recently by Ouellet et al.
Clinical Pharmacology & Therapeutics (2009); 85, 3, 277?282 as well as by
others elsewhere, is amenable to being used as a pharmacoeconomic vehicle. =

 Typically the CUI is derived in terms of patient benefit:risk, but could
easily be adapted to other tangible measures of value.


"Bonate, Peter" <Peter.Bonate
Sent by: owner-nmusers
23-Apr-2009 10:37

[NMusers] Pharmacoeconomic simulations

Is anyone aware of any papers or abstracts using computer-assisted trial
design that incorporates a pharmacoeconomic component to the simulation?
Or any pop pharmacokinetic-pharmacodynamic papers that include the same?
Pete bonate
Peter L. Bonate, PhD, FCP
Genzyme Corporation
Senior Director
Clinical Pharmacology and Pharmacokinetics
4545 Horizon Hill Blvd
San Antonio, TX 78229 USA
phone: 210-949-8662
fax: 210-949-8219
crackberry: 210-315-2713
"Beware of geeks bearing formulas". Written by Warren Buffet as part of
Berkshire Hathaway's 2009 Annual Report to Stockholders.

(image/gif attachment: 01-part)

Received on Thu Apr 23 2009 - 16:38:43 EDT

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: